Postinfectious Guillain-Barre syndrome in a patient with methimazole-induced agranulocytosis.
10.3904/kjim.2013.28.6.724
- Author:
Yoon Young CHO
1
;
Ji Young JOUNG
;
Hyemin JEONG
;
Dongmo JE
;
Yun Soo HONG
;
Sunghwan SUH
;
Sun Wook KIM
Author Information
1. Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. swkimmd@skku.edu
- Publication Type:Case Reports
- Keywords:
Agranulocytosis;
Graves disease;
Guillain-Barre syndrome
- MeSH:
Agranulocytosis/*chemically induced/diagnosis/therapy;
Antithyroid Agents/*adverse effects;
Female;
Graves Disease/diagnosis/*drug therapy;
Guillain-Barre Syndrome/diagnosis/*etiology/therapy;
Humans;
Immunoglobulins, Intravenous/therapeutic use;
Methimazole/*adverse effects;
Middle Aged;
Opportunistic Infections/diagnosis/*etiology/therapy;
Thyroidectomy;
Treatment Outcome
- From:The Korean Journal of Internal Medicine
2013;28(6):724-727
- CountryRepublic of Korea
- Language:English
-
Abstract:
Both Graves disease and Guillain-Barre syndrome (GBS) are autoimmune disorders caused by impaired self-tolerance mechanisms and triggered by interactions between genetic and environmental factors. GBS in patients who suffer from other autoimmune diseases is rarely reported, and the development of postinfectious GBS in a patient with Graves disease has not been previously reported in the literature. Herein, we report a patient with Graves disease who developed postinfectious GBS during a course of methimazole-induced agranulocytosis.
